U.S. FDA Approves Merck ’s Ervebo (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
RAHWAY, N.J.--(BUSINESS WIRE) August 3, 2023 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Ervebo, which is now...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Canada Health | Children | Drugs & Pharmacology | Ebola | Ebola Vaccine | Food and Drug Administration (FDA) | Merck | USA Health | Vaccines